A subtle change in our DNA can shape our appetite, our waistlines, and even our risk of disease.
Imagine your body harbors a hidden switch that influences how hungry you feel, how your body stores fat, and even whether you are predisposed to becoming overweight. This isn't science fiction; it's the reality of genetics and weight regulation. At the heart of this complex system is a hormone called ghrelin, often dubbed the "hunger hormone."
In 2006, a landmark study focused on a large Japanese cohort revealed a fascinating discovery: a tiny variation in the gene that produces ghrelin, known as the Leu72Met variant, appears to contribute significantly to overweight, particularly in middle-aged men. This finding opened a new window into understanding why some people struggle with weight management more than others, providing a compelling look at the intricate dance between our DNA and our health.
A single nucleotide change in the preproghrelin gene
Most significant effect observed in this demographic
Associated with increased BMI and waist circumference
To appreciate the Leu72Met discovery, we must first understand what ghrelin is and why it's so critical.
Ghrelin is a 28-amino-acid peptide hormone primarily produced in the stomach. It acts as a powerful orexigenic signal—meaning it stimulates appetite .
Before a meal, your ghrelin levels rise, sending a "time to eat" signal to your brain. After you eat, the levels fall, helping you feel satisfied .
Beyond hunger, ghrelin influences growth hormone release, fat storage, and the body's use of carbohydrates and fats for energy 6 .
The gene responsible for producing this hormone is the preproghrelin gene (GHRL). The Leu72Met variant is a single nucleotide polymorphism (SNP)—a small, common change in the DNA sequence of this gene. The switch of a single DNA base changes the 72nd amino acid in the preproghrelin protein from Leucine to Methionine 4 . Scientists believe this tiny alteration might change how the ghrelin hormone is processed or how it functions, potentially leading to its effects on body weight 6 .
The 2006 study, titled "Preproghrelin Leu72Met variant contributes to overweight in middle-aged men of a Japanese large cohort", provided some of the most compelling early evidence linking this genetic variant to weight gain in a specific population 1 .
The research was a cross-sectional analysis, meaning it examined a snapshot of a population at a single point in time. The scale and design of the study were crucial to its impact:
2,238 community-dwelling Japanese individuals aged 40 to 79 1
Determining Leu72Leu, Leu72Met, or Met72Met variants for each participant 1
BMI, waist circumference, lipids, glucose, and insulin levels 1
The results revealed a striking pattern that highlighted the importance of demographic specificity in genetic studies.
The overall frequency of the Met72 allele in the population was relatively common, with about 32.7% of people being carriers (Leu72Met genotype) and 4.0% having two copies (Met72Met genotype) 1 . However, the association with obesity was not uniform across all groups.
The most significant discovery was that middle-aged men who carried the 72Met allele showed 1 :
| Demographic Group | Association with Higher Body Weight/Waist Circumference? |
|---|---|
| Middle-Aged Men | Yes |
| Older Men | No |
| Women (All Ages) | No |
Interestingly, this strong association was not observed in women or in older men 1 . This suggests that the effect of the Leu72Met variant may be modulated by hormonal factors, such as testosterone or estrogen, or that its impact is most pronounced during specific periods of a person's life.
Furthermore, the study found no direct link between the Leu72Met variant and blood levels of lipids, glucose, or insulin, suggesting its primary effect is on body mass and fat distribution rather than directly on metabolic blood markers 1 .
The Japanese cohort study was a pivotal piece of a much larger puzzle. Research across the globe has continued to explore the role of this genetic variant, with complex and sometimes conflicting results:
A 2019 meta-analysis that pooled data from 11 studies found that the Leu72Met polymorphism is significantly associated with an increased risk of developing Type 2 Diabetes, particularly in Chinese populations 4 .
A 2023 study on Caucasians with Type 2 Diabetes found that the T allele (encoding Met72) was associated with a 2.5 times higher risk of hypertension, indicating a potential role in cardiovascular health 7 .
Another study in young Japanese women found that a different SNP in the preproghrelin gene was linked not only to higher BMI and fat mass but also to higher scores for "drive for thinness and body dissatisfaction," connecting genetics to the psychology of eating 3 .
| Associated Condition | Population Studied | Key Finding |
|---|---|---|
| Overweight/Obesity | Japanese, Javanese, Turkish-Cypriot | Stronger association in specific demographics (e.g., middle-aged men) 1 8 9 |
| Type 2 Diabetes | Multiple (Chinese subgroup) | Increased risk, especially under recessive genetic models 4 |
| Hypertension | Caucasians with Diabetes | T allele (Met72) linked to higher hypertension risk 7 |
| Altered Cholesterol | Turkish-Cypriot | Linked to lower HDL-C ("good" cholesterol) levels 9 |
Understanding how scientists study these genetic links helps demystify the process. Here are some of the essential tools and methods used in this field:
Large, well-defined groups of participants (like the Japanese cohort) that provide the biological and demographic data for analysis.
A technique used to amplify a specific DNA segment, making millions of copies for easy analysis.
A method used to identify genetic variants (like Leu72Met) by using enzymes that cut DNA at specific sequences.
Sophisticated software and models are used to determine if the link between a gene variant and a trait is statistically significant and not due to chance.
The following diagram illustrates the typical workflow in genetic association studies like the one examining the Leu72Met variant:
The discovery that the Preproghrelin Leu72Met variant contributes to overweight in middle-aged men was a crucial step in understanding the biological underpinnings of weight regulation. It demonstrated that our genetic blueprint can subtly influence our body's hunger signals and fat storage in a way that is dependent on our gender and age.
The Leu72Met story powerfully illustrates that in the quest to understand human health, we must consider not only the code written in our DNA but also the story of our lives.
Our genes may load the gun, but our environment and lifestyle pull the trigger when it comes to weight regulation and health outcomes.
References will be added here in the appropriate format.